Anileridine phosphate

This classification denotes an opioid receptor agonist with the molecular formula C22H28N2O2.H3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3584484N8V. European Medicines Agency schedules anileridine phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00533MIG. The term anileridine phosphate is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule anileridine phosphate under HS 29333990 and SITC 51574. As of Q4 2014, ANILERIDINE PHOSPHATE remains US FDA's Preferred Term for this commodity. Anileridine phosphate bears US NLM identifiers UMLS ID C0770428 and NCI Concept Code C87352. SMILES: CCOC(=O)C1(CCN(CC1)CCC2CCC(CC2)N)C3CCCCC3.OP(=O)(O)O.